LCTX
Price
$1.72
Change
-$0.04 (-2.27%)
Updated
Feb 4, 02:57 PM (EDT)
Capitalization
405.38M
29 days until earnings call
Intraday BUY SELL Signals
RVPH
Price
$0.28
Change
-$0.01 (-3.45%)
Updated
Feb 4, 03:08 PM (EDT)
Capitalization
34M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LCTX vs RVPH

Header iconLCTX vs RVPH Comparison
Open Charts LCTX vs RVPHBanner chart's image
Lineage Cell Therapeutics
Price$1.72
Change-$0.04 (-2.27%)
Volume$200
Capitalization405.38M
Reviva Pharmaceuticals Holdings
Price$0.28
Change-$0.01 (-3.45%)
Volume$3.5K
Capitalization34M
LCTX vs RVPH Comparison Chart in %
LCTX
Daily Signal:
Gain/Loss:
RVPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LCTX vs. RVPH commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and RVPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LCTX: $1.76 vs. RVPH: $0.29)
Brand notoriety: LCTX and RVPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 192% vs. RVPH: 20%
Market capitalization -- LCTX: $405.38M vs. RVPH: $34M
LCTX [@Biotechnology] is valued at $405.38M. RVPH’s [@Biotechnology] market capitalization is $34M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, LCTX is a better buy in the long-term than RVPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 7 TA indicator(s) are bullish while RVPH’s TA Score has 5 bullish TA indicator(s).

  • LCTX’s TA Score: 7 bullish, 1 bearish.
  • RVPH’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than RVPH.

Price Growth

LCTX (@Biotechnology) experienced а +7.98% price change this week, while RVPH (@Biotechnology) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

LCTX is expected to report earnings on Mar 05, 2026.

RVPH is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($405M) has a higher market cap than RVPH($34M). LCTX YTD gains are higher at: 5.389 vs. RVPH (3.799). LCTX has higher annual earnings (EBITDA): -19.68M vs. RVPH (-22.71M). LCTX has more cash in the bank: 40.5M vs. RVPH (13.2M). RVPH has less debt than LCTX: RVPH (113K) vs LCTX (2.62M). LCTX has higher revenues than RVPH: LCTX (10.8M) vs RVPH (0).
LCTXRVPHLCTX / RVPH
Capitalization405M34M1,191%
EBITDA-19.68M-22.71M87%
Gain YTD5.3893.799142%
P/E RatioN/AN/A-
Revenue10.8M0-
Total Cash40.5M13.2M307%
Total Debt2.62M113K2,319%
FUNDAMENTALS RATINGS
LCTX vs RVPH: Fundamental Ratings
LCTX
RVPH
OUTLOOK RATING
1..100
6970
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4191
P/E GROWTH RATING
1..100
5910
SEASONALITY SCORE
1..100
8513

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (66) in the null industry is in the same range as RVPH (92). This means that LCTX’s stock grew similarly to RVPH’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as RVPH (100). This means that LCTX’s stock grew similarly to RVPH’s over the last 12 months.

LCTX's SMR Rating (99) in the null industry is in the same range as RVPH (100). This means that LCTX’s stock grew similarly to RVPH’s over the last 12 months.

LCTX's Price Growth Rating (41) in the null industry is somewhat better than the same rating for RVPH (91). This means that LCTX’s stock grew somewhat faster than RVPH’s over the last 12 months.

RVPH's P/E Growth Rating (10) in the null industry is somewhat better than the same rating for LCTX (59). This means that RVPH’s stock grew somewhat faster than LCTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXRVPH
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signal:
Gain/Loss:
RVPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIRVX8.980.01
+0.11%
Goldman Sachs Intl Eq Div & Prem Inv
FSIDX18.25N/A
N/A
Fidelity Advisor Strategic Div & Inc I
VSCOX27.44-0.08
-0.29%
JPMorgan Small Cap Blend A
RPNLX13.19-0.22
-1.64%
RiverPark/Next Century Lg Gr Inst
DGLCX14.44-0.28
-1.90%
BNY Mellon Global Stock - C

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+14.29%
MDGL - LCTX
43%
Loosely correlated
-1.49%
VIR - LCTX
38%
Loosely correlated
-0.39%
RXRX - LCTX
36%
Loosely correlated
-1.91%
DSGN - LCTX
35%
Loosely correlated
-0.38%
ELVN - LCTX
34%
Loosely correlated
-2.02%
More

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-1.03%
ALT - RVPH
50%
Loosely correlated
-1.44%
INM - RVPH
29%
Poorly correlated
-3.64%
LCTX - RVPH
29%
Poorly correlated
+14.29%
INDP - RVPH
29%
Poorly correlated
-7.96%
NEVPF - RVPH
27%
Poorly correlated
N/A
More